Product CartHuman Induced Pluripotent Cells (Human Disease Model iPS Cell Lines)
Disease-specific iPS Cell Lines
• Reprogrammed using standard OSKM factors
• Certified pluripotent with positive immunostaining
• Study the disease process more accurately with better models
SBI and DV Biologics have partnered to develop novel Human iPS cell lines from patient-derived sources. Utilizing iPS cell lines from these disorders represents an opportunity to recapitulate both normal and pathological tissue formation in vitro for the ideal drug development screening cell line to facilitate new therapeutic discovery and disease modeling.
• Type I Diabetes: Autoimmune Model
• Metachromatic Leukodystrophy: Polyneuropathy Model
• Muscular Dystrophy: Muscle Development Model
• Glioblastoma: Tumorigenic Model
Glioblastoma multiforme iPS cell line certified positive for pluripotency markers.
The human patient dermal fibroblasts are derived from cultured skin explants from a single donor for clear genetic background (Glioblastoma diagnosed by both MRI and CT-SCAN at age 40). Glioblastoma multiforme (GBM) is the most common and most aggressive malignant primary brain tumor in humans.
| Description | Cat# | Size | Price | ||
|---|---|---|---|---|---|
| Human Amyotrophic lateral sclerosis iPS Cell Line (Academic customers) | SC603A-ALS-GVO-SBI | 2x10^5 cells | 2524 € | DETAILS |
|
| Human Amyotrophic lateral sclerosis iPS Cell Line (Commercial customers) | SC603B-ALS-GVO-SBI | 2x10^5 cells | 4024 € | DETAILS |
|
| Human Glioblastoma multiforme iPS Cell Line (Academic customers) | SC605A-GBM-GVO-SBI | 2x10^5 cells | 2524 € | DETAILS |
|
| Human Glioblastoma multiforme iPS Cell Line (Commercial customers) | SC605B-GBM-GVO-SBI | 2x10^5 cells | 4024 € | DETAILS |
|
| Human iPS Cell Line (Wild-type reference control) includes 500 ml Human ESC/iPSC Growth Medium (SC100M-1) | SC600A-WT-GVO-SBI | 2 x 10e5 cells | 1219 € | DETAILS |
|
| Human MLD (Metachromatic Leukodystrophy) Neurodegeneration iPS Cell Line (Academic customers) | SC601A-MLD-GVO-SBI | 2x10^5 cells | 2524 € | DETAILS |
|
| Human MLD (Metachromatic Leukodystrophy) Neurodegeneration iPS Cell Line (Commercial customers) | SC601B-MLD-GVO-SBI | 2x10^5 cells | 4024 € | DETAILS |
|
| Human Muscular Dystrophy iPS Cell Line (Academic customers) | SC604A-MD-GVO-SBI | 2x10^5 cells | 2524 € | DETAILS |
|
| Human Muscular Dystrophy iPS Cell Line (Commercial customers) | SC604B-MD-GVO-SBI | 2x10^5 cells | 4024 € | DETAILS |
|
| Human Parkinson's Early Onset Disease iPS Cell Line (Academic customers) | SC608A-PD-GVO-SBI | 2x10^5 cells | 2524 € | DETAILS |
|
| Human Parkinson's Early Onset Disease iPS Cell Line (Commercial customers) | SC608B-PD-GVO-SBI | 2x10^5 cells | 4024 € | DETAILS |
|
| Human Parkinson's Late Onset Disease iPS Cell Line (Academic customers) | SC607A-PD-GVO-SBI | 2x10^5 cells | 2524 € | DETAILS |
|
| Human Parkinson's Late Onset Disease iPS Cell Line (Commercial customers) | SC607B-PD-GVO-SBI | 2x10^5 cells | 4024 € | DETAILS |
|
| Human Type I Diabetes iPS Cell Line (Academic customers) | SC602A-DT1-GVO-SBI | 2x10^5 cells | 2524 € | DETAILS |
|
| Human Type I Diabetes iPS Cell Line (Commercial customers) | SC602B-DT1-GVO-SBI | 2x10^5 cells | 4024 € | DETAILS |
|
| Human Type II Diabetes iPS Cell Line (Academic customers) | SC606A-DT2-GVO-SBI | 2x10^5 cells | 2524 € | DETAILS |
|
| Human Type II Diabetes iPS Cell Line (Commercial customers) | SC606B-DT2-GVO-SBI | 2x10^5 cells | 4024 € | DETAILS |
|
